| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $14.03M | - | |
| Dir | 22.0K | $1.21M | - | |
| CFO | 19.5K | $1.07M | - | |
| Other | 19.4K | $1.06M | -3,786 | |
| Other | 17.0K | $933.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $48.25 | $1,206,243.36 | -2.1% | +31.5% | +81.3% | |
| Jan 27, 2023 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $51.47 | $1,286,797.52 | -3.2% | -7.0% | +15.6% | |
| Dec 28, 2022 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $40.93 | $1,023,290.03 | -3.3% | +11.9% | +64.1% | |
| Nov 28, 2022 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $54.03 | $1,350,826.80 | -2.8% | -7.8% | +32.5% | |
| Oct 26, 2022 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $54.81 | $1,370,191.05 | -2.0% | -5.9% | -29.1% | |
| Sep 28, 2022 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $64.61 | $1,615,160.24 | -4.1% | -38.7% | -31.7% | |
| Aug 29, 2022 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $66.84 | $1,671,084.48 | -2.7% | -18.9% | -23.1% | |
| Jul 27, 2022 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $75.91 | $1,897,747.33 | -1.4% | -33.5% | -29.8% | |
| Jun 29, 2022 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $61.59 | $1,539,861.52 | -4.1% | +1.0% | -9.5% | |
| Aug 6, 2021 | Tomsicek Michael John | Chief Financial Officer | Sale+OE | 25,000 | $138.52 | $3,462,926.36 | -71.9% | -32.0% | -40.5% |